11:31 AM EDT, 05/08/2025 (MT Newswires) -- Bio-Techne ( TECH ) has entered into a partnership with genome engineering firm Kytopen to accelerate cell therapy manufacturing, the companies said Thursday.

The collaboration will focus on combining their technologies, TcBuster GMP non-viral genome engineering system and Flowfect Tx GMP cellular engineering platform, according to a joint statement.

Shares of Bio-Techne ( TECH ) were up more than 2% in recent trading.

Price: 49.99, Change: +1.24, Percent Change: +2.54